{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:37:57Z","timestamp":1792802277617,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04974-x","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:30:14Z","timestamp":1792740614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II\u2013III colon cancer"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-7852","authenticated-orcid":false,"given":"Ahmet Burak","family":"A\u011fao\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-942X","authenticated-orcid":false,"given":"Ferhat","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-593X","authenticated-orcid":false,"given":"Mustafa","family":"\u015eahbazlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-7574","authenticated-orcid":false,"given":"Atike Pinar","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"4974_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12876-025-04086-5","volume":"25","author":"H Pan","year":"2025","unstructured":"Pan H, Tang Y, Zhu H et al (2025) Global burden, trends, and risk factors of early-onset and late-onset colorectal cancer from 1990 to 2021, with projections to 2040: a population-based study. BMC Gastroenterol 25:486. https:\/\/doi.org\/10.1186\/s12876-025-04086-5","journal-title":"BMC Gastroenterol"},{"key":"4974_CR2","doi-asserted-by":"publisher","first-page":"e2525668","DOI":"10.1001\/jamanetworkopen.2025.25668","volume":"8","author":"A De Stefano","year":"2025","unstructured":"De Stefano A, Cardone C, Avallone A (2025) Optimizing Adjuvant Treatment for Older Patients With Stage III Colon Cancer\u2014The Oxaliplatin Dilemma. JAMA Netw Open 8:e2525668. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.25668","journal-title":"JAMA Netw Open"},{"key":"4974_CR3","doi-asserted-by":"publisher","first-page":"101639","DOI":"10.1016\/j.jgo.2023.101639","volume":"15","author":"MR Moreno-Carmona","year":"2024","unstructured":"Moreno-Carmona MR, Serra-Prat M, Riera SA et al (2024) Effect of frailty on postoperative complications, mortality, and survival in older patients with non-metastatic colon cancer: A systematic review and meta-analysis. J Geriatric Oncol 15:101639. https:\/\/doi.org\/10.1016\/j.jgo.2023.101639","journal-title":"J Geriatric Oncol"},{"key":"4974_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/cncr.27755","volume":"119","author":"A Abraham","year":"2013","unstructured":"Abraham A, Habermann EB, Rothenberger DA et al (2013) Adjuvant chemotherapy for stage III colon cancer in the oldest old: Results beyond clinical guidelines. Cancer 119:395\u2013403. https:\/\/doi.org\/10.1002\/cncr.27755","journal-title":"Cancer"},{"key":"4974_CR5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/cancers16101820","volume":"16","author":"CDJ O\u2019Donnell","year":"2024","unstructured":"O\u2019Donnell CDJ, Hubbard J, Jin Z (2024) Updates on the Management of Colorectal Cancer in Older Adults. Cancers 16:1820. https:\/\/doi.org\/10.3390\/cancers16101820","journal-title":"Cancers"},{"key":"4974_CR6","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.1038\/s41598-022-13426-4","volume":"12","author":"Y Kim","year":"2022","unstructured":"Kim Y, Song K, Kang CM, Lee H (2022) Impact of preoperative laboratory frailty index on mortality and clinical outcomes in older surgical patients with cancer. Sci Rep 12:9200. https:\/\/doi.org\/10.1038\/s41598-022-13426-4","journal-title":"Sci Rep"},{"key":"4974_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/03007995.2022.2139053","volume":"39","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang X, Wang M et al (2023) Effect of comorbidity assessed by the Charlson Comorbidity Index on the length of stay, costs, and mortality among colorectal cancer patients undergoing colorectal surgery. Curr Med Res Opin 39:187\u2013195. https:\/\/doi.org\/10.1080\/03007995.2022.2139053","journal-title":"Curr Med Res Opin"},{"key":"4974_CR8","doi-asserted-by":"publisher","first-page":"101363","DOI":"10.1016\/j.jgo.2022.08.012","volume":"14","author":"GR Williams","year":"2023","unstructured":"Williams GR, Outlaw D, Harvey RD et al (2023) Chemotherapy dosing in older adults with cancer: One size does NOT fit all. J Geriatric Oncol 14:101363. https:\/\/doi.org\/10.1016\/j.jgo.2022.08.012","journal-title":"J Geriatric Oncol"},{"key":"4974_CR9","doi-asserted-by":"publisher","first-page":"20794","DOI":"10.18632\/oncotarget.15285","volume":"8","author":"Y Tian","year":"2017","unstructured":"Tian Y, Xu B, Yu G et al (2017) Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection. Oncotarget 8:20794\u201320801. https:\/\/doi.org\/10.18632\/oncotarget.15285","journal-title":"Oncotarget"},{"key":"4974_CR10","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, Rainfray M, Mathoulin-P\u00e9lissier S et al (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23:2166\u20132172. https:\/\/doi.org\/10.1093\/annonc\/mdr587","journal-title":"Ann Oncol"},{"key":"4974_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12957-023-03186-4","volume":"21","author":"L Huang","year":"2023","unstructured":"Huang L, Li Z, Jian M et al (2023) Application of MFI-5 in severe complications and unfavorable outcomes after radical resection of colorectal cancer. World J Surg Onc 21:307. https:\/\/doi.org\/10.1186\/s12957-023-03186-4","journal-title":"World J Surg Onc"},{"key":"4974_CR12","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/jnci\/djaf281","volume":"117","author":"E Cheng","year":"2025","unstructured":"Cheng E, Shi Q, Shields AF et al (2025) Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB\/SWOG 80702 (Alliance). JNCI: J Natl Cancer Inst 117:2643\u20132652. https:\/\/doi.org\/10.1093\/jnci\/djaf281","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"4974_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/ol.2022.13261","volume":"23","author":"X Chu","year":"2022","unstructured":"Chu X, Xue P, Zhu S (2022) Management of chemotherapy dose intensity for metastatic colorectal cancer (Review). Oncol Lett 23:141. https:\/\/doi.org\/10.3892\/ol.2022.13261","journal-title":"Oncol Lett"},{"key":"4974_CR14","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.3390\/jcm12155041","volume":"12","author":"H Maeda","year":"2023","unstructured":"Maeda H, Takahashi M, Seo S, Hanazaki K (2023) Frailty and Colorectal Surgery: Review and Concept of Cancer Frailty. JCM 12:5041. https:\/\/doi.org\/10.3390\/jcm12155041","journal-title":"JCM"},{"key":"4974_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s41999-024-00960-9","volume":"15","author":"L Ding","year":"2024","unstructured":"Ding L, Hua Q, Xu J et al (2024) Predictive performance of different measures of frailty (CFS, mFI-11, mFI-5) on postoperative adverse outcomes among colorectal cancer patients: a diagnostic meta-analysis. Eur Geriatr Med 15:471\u2013479. https:\/\/doi.org\/10.1007\/s41999-024-00960-9","journal-title":"Eur Geriatr Med"},{"key":"4974_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12957-023-03150-2","volume":"21","author":"T Ogata","year":"2023","unstructured":"Ogata T, Sadakari Y, Nakane H et al (2023) The five-item modified frailty index predicts long-term outcomes in elderly patients undergoing colorectal cancer surgery. World J Surg Onc 21:268. https:\/\/doi.org\/10.1186\/s12957-023-03150-2","journal-title":"World J Surg Onc"},{"key":"4974_CR17","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1111\/jgs.17977","volume":"70","author":"O Ysea-Hill","year":"2022","unstructured":"Ysea-Hill O, Gomez CJ, Mansour N et al (2022) The association of a frailty index from laboratory tests and vital signs with clinical outcomes in hospitalized older adults. J Am Geriatr Soc 70:3163\u20133175. https:\/\/doi.org\/10.1111\/jgs.17977","journal-title":"J Am Geriatr Soc"},{"key":"4974_CR18","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.14336\/AD.2024.0280","volume":"16","author":"PP Chmielewski","year":"2025","unstructured":"Chmielewski PP, Data K, Strzelec B et al (2025) Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions. Aging disease 16:1853. https:\/\/doi.org\/10.14336\/AD.2024.0280","journal-title":"Aging disease"},{"key":"4974_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00520-023-08173-9","volume":"31","author":"IM Sousa","year":"2023","unstructured":"Sousa IM, Silva FM, Das Virgens IPA et al (2023) Independent and joint association of sarcopenia and frailty with mortality in older patients with gastrointestinal cancer: a cohort study with prospective data collection. Support Care Cancer 31:728. https:\/\/doi.org\/10.1007\/s00520-023-08173-9","journal-title":"Support Care Cancer"},{"key":"4974_CR20","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s41999-025-01352-3","volume":"16","author":"DM Alcaide","year":"2025","unstructured":"Alcaide DM, Cilla F, Kort E, D\u2019Amelio P (2025) Frailty detection tools in geriatric rehabilitation: a systematic review. Eur Geriatr Med 16:2097\u20132113. https:\/\/doi.org\/10.1007\/s41999-025-01352-3","journal-title":"Eur Geriatr Med"},{"key":"4974_CR21","doi-asserted-by":"publisher","first-page":"afac309","DOI":"10.1093\/ageing\/afac309","volume":"52","author":"DG Sapp","year":"2023","unstructured":"Sapp DG, Cormier BM, Rockwood K et al (2023) The frailty index based on laboratory test data as a tool to investigate the impact of frailty on health outcomes: a systematic review and meta-analysis. Age Ageing 52:afac309. https:\/\/doi.org\/10.1093\/ageing\/afac309","journal-title":"Age Ageing"},{"key":"4974_CR22","doi-asserted-by":"publisher","unstructured":"Nagae M, Umegaki H, Nakashima H, Nishiuchi T (2025) HALP and FI-Lab Scores in Hospitalized Older Adults: A Retrospective Comparative Study of Adverse Outcomes. https:\/\/doi.org\/10.1007\/s11606-025-09889-6. J GEN INTERN MED","DOI":"10.1007\/s11606-025-09889-6"},{"key":"4974_CR23","doi-asserted-by":"publisher","first-page":"104667","DOI":"10.1016\/j.archger.2022.104667","volume":"100","author":"CH Soh","year":"2022","unstructured":"Soh CH, Guan L, Reijnierse EM et al (2022) Comparison of the modified Frailty-Index based on laboratory tests and the Clinical Frailty Scale in predicting mortality among geriatric rehabilitation inpatients: RESORT. Arch Gerontol Geriatr 100:104667. https:\/\/doi.org\/10.1016\/j.archger.2022.104667","journal-title":"Arch Gerontol Geriatr"},{"key":"4974_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1186\/s12885-022-10198-y","volume":"22","author":"D Breadner","year":"2022","unstructured":"Breadner D, Loree JM, Cheung WY et al (2022) The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis. BMC Cancer 22:1119. https:\/\/doi.org\/10.1186\/s12885-022-10198-y","journal-title":"BMC Cancer"},{"key":"4974_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clcc.2023.02.007","volume":"22","author":"J Sgouros","year":"2023","unstructured":"Sgouros J, Gkoura S, Spathas N et al (2023) Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role? Clin Colorectal Cancer 22:238\u2013244. https:\/\/doi.org\/10.1016\/j.clcc.2023.02.007","journal-title":"Clin Colorectal Cancer"},{"key":"4974_CR26","doi-asserted-by":"publisher","first-page":"e2525660","DOI":"10.1001\/jamanetworkopen.2025.25660","volume":"8","author":"JW Bong","year":"2025","unstructured":"Bong JW, Lee H, Jeong S, Kang S (2025) Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer. JAMA Netw Open 8:e2525660. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.25660","journal-title":"JAMA Netw Open"},{"key":"4974_CR27","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/bjc.2014.496","volume":"111","author":"T Kalsi","year":"2014","unstructured":"Kalsi T, Babic-Illman G, Fields P et al (2014) The impact of low-grade toxicity in older people with cancer undergoing chemotherapy. Br J Cancer 111:2224\u20132228. https:\/\/doi.org\/10.1038\/bjc.2014.496","journal-title":"Br J Cancer"},{"key":"4974_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/curroncol30010069","volume":"30","author":"B P\u00e9csi","year":"2023","unstructured":"P\u00e9csi B, Mangel L (2023) Real-Life Effectivity of Dose Intensity Reduction of First-Line mFOLFIRI-Based Treatment of Metastatic Colorectal Cancers: Sometimes Less Is More. Curr Oncol 30:908\u2013922. https:\/\/doi.org\/10.3390\/curroncol30010069","journal-title":"Curr Oncol"},{"key":"4974_CR29","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1097\/JS9.0000000000001175","volume":"110","author":"Z Kuang","year":"2024","unstructured":"Kuang Z, Wang J, Liu K et al (2024) Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II\u2013III colon cancer: a meta-analysis. Int J Surg 110:3030\u20133038. https:\/\/doi.org\/10.1097\/JS9.0000000000001175","journal-title":"Int J Surg"},{"key":"4974_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.21873\/invivo.13459","volume":"38","author":"A Shimizu","year":"2024","unstructured":"Shimizu A, Fukasawa M, Endo R et al (2024) Association of Geriatric Nutritional Risk Index With Adverse Event and Treatment Duration in Adjuvant Chemotherapy for Patients With Colorectal Cancer. Vivo 38:453\u2013459. https:\/\/doi.org\/10.21873\/invivo.13459","journal-title":"Vivo"},{"key":"4974_CR31","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/cncr.35204","volume":"130","author":"BJ Caan","year":"2024","unstructured":"Caan BJ, Brown JC, Lee C et al (2024) Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial. Cancer 130:1858\u20131868. https:\/\/doi.org\/10.1002\/cncr.35204","journal-title":"Cancer"},{"key":"4974_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1159\/000540334","volume":"102","author":"M Erciyestepe","year":"2024","unstructured":"Erciyestepe M, Selvi O, Din\u00e7 G et al (2024) Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients. Oncology 102:1009\u20131017. https:\/\/doi.org\/10.1159\/000540334","journal-title":"Oncology"},{"key":"4974_CR33","doi-asserted-by":"publisher","first-page":"e38809","DOI":"10.1016\/j.heliyon.2024.e38809","volume":"10","author":"O Acar","year":"2024","unstructured":"Acar O, Balcik OY, Urun M et al (2024) Positive Lymph Node Ratio as a new prognostic score in Geriatric patients with operated gastric cancer. Heliyon 10:e38809. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38809","journal-title":"Heliyon"},{"key":"4974_CR34","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie J, Wang Y, Loree JM et al (2025) Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2\/3 DYNAMIC-III trial. Nat Med 31:4291\u20134300. https:\/\/doi.org\/10.1038\/s41591-025-04030-w","journal-title":"Nat Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04974-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:02:27Z","timestamp":1792800147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04974-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4974"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04974-x","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Manisa Celal Bayar University Faculty of Medicine Health Sciences Ethics Committee (Approval No: 3314; July 16, 2025). Owing to the retrospective and anonymized nature of the study, informed consent for publication was not required in accordance with institutional and journal policies.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}